Search Results - "Miceli, M H"

Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections by Ostrosky-Zeichner, L., Nguyen, M. H., Bubalo, J., Alexander, B. D., Miceli, M. H., Pappas, P. G., Jiang, J., Song, Y., Thompson, G. R.

“…Introduction ‘Real-world’ data for mold-active triazoles (MATs) in the treatment of invasive fungal infections (IFIs) are lacking. This study evaluated usage…”
Get full text

Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients by MICELI, M. H, DONG, L, GRAZZIUTTI, M. L, FASSAS, A, THERTULIEN, R, VAN RHEE, F, BARLOGIE, B, ANAISSIE, E. J

“…We evaluated the risk factors for infection of 367 consecutive myeloma patients who underwent high-dose melphalan and autologous stem cell transplantation…”
Get full text

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model by GRAZZIUTTI, M. L, DONG, L, ANAISSIE, E. J, MICELI, M. H, KRISHNA, S. G, KIWAN, E, SYED, N, FASSAS, A, VAN RHEE, F, KLAUS, H, BARLOGIE, B

“…Melphalan-based autologous stem cell transplant (Mel-ASCT) is a standard therapy for multiple myeloma, but is associated with severe oral mucositis (OM). To…”
Get full text

Transmission of infection to liver transplant recipients from donors with infective endocarditis: lessons learned by Miceli, M.H., Gonulalan, M., Perri, M.B., Samuel, L., Al Fares, M.A., Brown, K., Bruno, D.A., Zervos, M., Ramesh, M., Alangaden, G.

“…Donors not meeting standard criteria, such as those with bacteremia, are now being used in response to the increasing need for organs for transplantation…”
Get full text

Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008–2019 by Jenks, J.D., Seidel, D., Cornely, O.A., Chen, S., van Hal, S., Kauffman, C., Miceli, M.H., Heinemann, M., Christner, M., Jover Sáenz, A., Burchardt, A., Kemmerling, B., Herbrecht, R., Steinmann, J., Shoham, S., Gräber, S., Pagano, L., Deeren, D., Aslam, S., Taplitz, R., Revankar, S.G., Baddley, J., Mehta, S.R., Reed, S., Slavin, M.A., Hoenigl, M.

“…Lomentospora prolificans is an emerging cause of serious invasive fungal infections. Optimal treatment of these infections is unknown, although…”
Get full text

Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients by GRAZZIUTTI, M. L, DONG, L, MICELI, M. H, COTTLER-FOX, M, KRISHNA, S. G, FASSAS, A, VAN RHEE, F, BARLOGIE, B. M, ANAISSIE, E. J

“…The duration of neutropenia (absolute neutrophil count (ANC) < or = 100/microl) identifies cancer patients at risk for infection. A test that precedes ANC > or…”
Get full text

Loss of hepatitis A virus (HAV) antibodies after peripheral stem cell transplantation (PSCT) by DIGNANI, M. C, MICELI, M. H, ROSA, C. M, GATICA, J, MARTINEZ-ROLON, J, PIZZOLATO, M

“…The majority of patients with hepatitis A have a benign course, but some may develop fulminant hepatitis and hematological complications. Peripheral stem cell…”
Get full text

Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation by Fassas, AB-T, Miceli, MH, Grazzlutti, M, Dong, L, Barlogie, B, Anaissie, E

“…The value of serum C-reactive protein (CRP) levels as a predictor of complications in neutropenic patients needs to be further defined. We sought to identify…”
Get full text

Avascular Necrosis of Femoral and/or Humeral Heads in Multiple Myeloma: Results of a Prospective Study of Patients Treated With Dexamethasone-Based Regimens and High-Dose Chemotherapy by TALAMO, Giampaolo, ANGTUACO, Edgardo, WALKER, Ronald C, LI DONG, MICELI, Marisa H, ZANGARI, Maurizio, TRICOT, Guido, BARLOGIE, Bart, ANAISSIE, Elias

“…To assess the prevalence, time of onset, risk factors, and outcome of avascular necrosis (AVN) of bone in patients with multiple myeloma undergoing…”
Get full text

Leaving previously implanted central venous catheters (ports) in place does not increase morbidity in patients undergoing autologous peripheral stem cell transplantation by MICELI, M. H, DONG, L, CORIA, P, VILA, A, ESTRADA, S, GARCIA-DAMIANO, M. C, MARTINEZ-ROLON, J, MILONE, G, DIGNANI, M. C

“…We sought to assess if leaving in place a previously inserted noncolonized or infected implantable catheter (IC) is associated with an increase in morbidity in…”
Get full text

A case of person-to-person transmission of Q fever from an active duty serviceman to his spouse by Miceli, Marisa H, Veryser, Andrea Kay, Anderson, Alicia D, Hofinger, Diedre, Lee, Samuel A, Tancik, Corey

“…Coxiella burnetii has recently gained military relevance given its potential as a bioterrorism agent, and the multiple cases reported among U.S. military…”
Get more information

Emerging opportunistic yeast infections by Miceli, Marisa H, MD, Díaz, José A, MD, Lee, Samuel A, Dr

“…Summary A growing population of immunosuppressed patients has resulted in increasingly frequent diagnoses of invasive fungal infections, including those caused…”
Get full text

When a Paradoxical Increase in Serum Galactomannan Antigen during Caspofungin Therapy Is Not Paradoxical after All by Miceli, Marisa H., Anaissie, Elias J.

Get full text

Blastomycosis by Castillo, Caroline G., MD, Kauffman, Carol A., MD, Miceli, Marisa H., MD

“…Blastomycosis is an endemic fungal infection due to Blastomyces dermatitidis that most commonly causes pneumonia; but the organism can disseminate to any organ…”
Get full text

Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? by Costa, Silvia F, Miceli, Marisa H, Anaissie, Elias J

“…Nosocomial bacteraemia is associated with significant morbidity, mortality, and cost worldwide, and is most commonly caused by coagulase-negative staphylococci…”
Get more information

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients by Miceli, Marisa H, Chandrasekar, Pranatharthi

“…Liposomal amphotericin B is a "true" liposomal formulation of amphotericin B with greatly reduced nephrotoxicity and minimal infusion-related toxicity. This…”
Get full text

18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious Episodes by Mahfouz, T, Miceli, M H, Saghafifar, F, Stroud, S, Jones-Jackson, L, Walker, R, Grazziutti, M L, Purnell, G, Fassas, A, Tricot, G, Barlogie, B, Anaissie, E

“…Correctly identifying infection in cancer patients can be challenging. Limited data suggest that positron emission tomography (PET) using fluorine-18…”
Get full text

Loss of hepatitis A virus by Dignani, M C, Miceli, M H, Rosa, C M, Gatica, J, Ma, Pizzolato, M

Get full text

Effect of underlying immune compromise on the manifestations and outcomes of group A streptococcal bacteremia by Linder, Kathleen A., MD, Alkhouli, Leen, MD, Ramesh, Mayur, MD, Alangaden, George A., MD, Kauffman, Carol A., MD, Miceli, Marisa H., MD

“…Abstract Background Group A streptococcal bloodstream infection is the most common presentation of invasive group A streptococcal disease. We sought to…”
Get full text

Colonization and molecular epidemiology of coagulase-negative Staphylococcal bacteremia in cancer patients: A pilot study by Costa, Silvia F., Barone, Antonio A., Miceli, Marisa H., van der Heijden, Inneke M., Soares, Robson E., Levin, Anna S., Anaissie, Elias J.

“…Controversy surrounds the source (skin vs mucosa) of coagulase-negative staphylococci (CoNS) bacteremia in cancer patients. Determining the source of this…”
Get full text